An independent role of protective HLA class II alleles in rheumatoid arthritis severity and susceptibility
- PMID: 16142711
- DOI: 10.1002/art.21272
An independent role of protective HLA class II alleles in rheumatoid arthritis severity and susceptibility
Abstract
Objective: To prospectively investigate the effect of the DERAA-encoding HLA alleles on disease susceptibility and severity in a large cohort of patients with rheumatoid arthritis (RA), and to differentiate protective effects from non-predisposition by comparing subgroups of patients with an equal amount of predisposition alleles.
Methods: HLA class II alleles were determined in 440 patients with early RA and in 423 healthy controls. In order to study the effect of HLA on disease severity, radiographic joint destruction was evaluated, using the modified Sharp/van der Heijde method, during 4 years of followup.
Results: The presence of DERAA-encoding HLA-DRB1 alleles conferred a lower risk of developing RA for both the presence and absence of SE alleles (odds ratio 0.6). At all time points, radiographic destruction was significantly less severe in DERAA-positive patients with 1 SE allele compared with DERAA-negative patients with 1 SE allele. Additionally, a protective effect of DERAA was detected in the groups of patients who were prone to having more severe disease because of the presence of anti-cyclic citrullinated peptide antibodies or because of smoking.
Conclusion: DERAA-encoding HLA-DRB1 alleles independently protect against RA and are associated with less severe disease.
Similar articles
-
The DERAA HLA-DR alleles in patients with early polyarthritis: protection against severe disease and lack of association with rheumatoid arthritis autoantibodies.Arthritis Rheum. 2009 Mar;60(3):698-707. doi: 10.1002/art.24353. Arthritis Rheum. 2009. PMID: 19248090
-
Expression of QK/QR/RRRAA or DERAA motifs at the third hypervariable region of HLA-DRB1 and disease severity in rheumatoid arthritis.J Rheumatol. 2002 Jul;29(7):1358-65. J Rheumatol. 2002. PMID: 12136889
-
Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins.Arthritis Rheum. 2005 Nov;52(11):3433-8. doi: 10.1002/art.21385. Arthritis Rheum. 2005. PMID: 16255021
-
Redefining the HLA and RA association: to be or not to be anti-CCP positive.J Autoimmun. 2005;25 Suppl:21-5. doi: 10.1016/j.jaut.2005.09.005. Epub 2005 Oct 27. J Autoimmun. 2005. PMID: 16257178 Review.
-
HLA and RA revisited: citrullinated food for the SE hypothesis, the DR6 effect, and NIMA.Hum Immunol. 2006 Jun;67(6):454-9. doi: 10.1016/j.humimm.2006.03.016. Epub 2006 Apr 3. Hum Immunol. 2006. PMID: 16728269 Review.
Cited by
-
A genetic study on C5-TRAF1 and progression of joint damage in rheumatoid arthritis.Arthritis Res Ther. 2015 Jan 8;17(1):1. doi: 10.1186/s13075-014-0514-0. Arthritis Res Ther. 2015. PMID: 25566937 Free PMC article.
-
Advantages of Chinese herbal medicine in treating rheumatoid arthritis: a focus on its anti-inflammatory and anti-oxidative effects.Front Med (Lausanne). 2024 Mar 7;11:1371461. doi: 10.3389/fmed.2024.1371461. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38515982 Free PMC article. Review.
-
The Protective Role of HLA-DRB1(∗)13 in Autoimmune Diseases.J Immunol Res. 2015;2015:948723. doi: 10.1155/2015/948723. Epub 2015 Oct 29. J Immunol Res. 2015. PMID: 26605347 Free PMC article.
-
HLA-DRB1 allelic epitopes that associate with autoimmune disease risk or protection activate reciprocal macrophage polarization.Sci Rep. 2021 Jan 28;11(1):2599. doi: 10.1038/s41598-021-82195-3. Sci Rep. 2021. PMID: 33510427 Free PMC article.
-
HLA Class II Polymorphism and Humoral Immunity Induced by the SARS-CoV-2 mRNA-1273 Vaccine.Vaccines (Basel). 2022 Mar 6;10(3):402. doi: 10.3390/vaccines10030402. Vaccines (Basel). 2022. PMID: 35335034 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials